Rezatapopt shows promising efficacy in treating various tumors with TP53 Y220C mutations, highlighting its potential as a ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 / EINPresswire.com / -- What Is The Cellular Tumor Antigen p53 Market Size And Growth?

A new study from Karolinska Institutet, published in Nature Communications, reveals that cyclin-dependent kinases (CDK) ...

In a groundbreaking review published in Current Molecular Pharmacology, a team led by Dr. Jhi Biau Foo from Taylor’s University unveils the pivotal role of mutant p53 (mutp53) in driving cancer ...

PMV Pharmaceuticals Inc.’s rezatapopt yielded impressive overall response data in ovarian cancer, prompting the firm to aim ...

The firm said it will enroll more ovarian cancer patients in its ongoing Phase II trial to gather data for a regulatory submission for rezatapopt to the FDA.

Dandelion root extract (DRE) exhibits promising anti-cancer properties, selectively eliminating colon cancer cells without harming healthy ones. Studi ...

In a twist worthy of molecular drama, scientists at Karolinska Institutet have uncovered a surprising new role for a ...

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities Histology-agnostic therapies: by focusing on common mutations across various cancers, this approach ...

Researchers at Moffitt Cancer Center have created the first genetically engineered model of lung cancer in naked mole rats, a ...